This study, called the EXPLORE MG Registry, aims to create a collection of biological samples and health information from people with Myasthenia Gravis (MG) at Yale University. Researchers will collect blood samples to better understand MG, including how it progresses, how it's treated, and its impact on health. The goal is to build a resource for current and future research projects to answer important questions about MG. You may be able to join if you are an adult diagnosed with Myasthenia Gravis and receive care or research interventions at the Yale Department of Neurology. The main goal of this study is to successfully collect blood samples, which will be reported at the end of the 8-year sample collection period. The current recruitment status is unclear.

Study design

This is an observational study planning to enroll 800 participants. It is not a drug trial but a registry to collect information and samples.

What's involved

If you join, you will have approximately 100 cc (less than 1/2 cup) of blood drawn. The study will collect peripheral blood, stool, and information about your disease status, course, and treatment.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint for successful blood draws is measured at 8 years, indicating a long-term collection period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.